Results 211 to 214 of about 28,203 (214)
Some of the next articles are maybe not open access.
Emerging carbapenemases: a global perspective
International Journal of Antimicrobial Agents, 2010The celestial rise in antibiotic resistance among Gram-negative bacteria has challenged both the scientific and pharmaceutical sectors. The hallmark of this general increase is the unbridled dissemination of carbapenem resistance genes, namely KPC, OXA and metallo-β-lactamase variants.
openaire +3 more sources
Clinically significant carbapenemases: an update
Current Opinion in Infectious Diseases, 2008To provide a brief synopsis of studies which have extended our understanding of carbapenem resistance in clinical isolates in terms of epidemiology, mechanism of action and genetic factors affecting their carriage and spread.Studies published in the last 18 months continue to confirm that VIM-2 is the dominant metallo-beta-lactamase in Pseudomonas ...
openaire +3 more sources
Journal of Microbiological Methods, 2019
A simple EDTA synergistic carbapenem inactivation method (esCIM) based on the simplified carbapenem inactivation method (sCIM) and EDTA synergistic carbapenem inactivation test (eCIM) detected the levels of metallo-β-lactamases (MBLs) carbapenemase.
Chengcheng Wang +9 more
openaire +3 more sources
A simple EDTA synergistic carbapenem inactivation method (esCIM) based on the simplified carbapenem inactivation method (sCIM) and EDTA synergistic carbapenem inactivation test (eCIM) detected the levels of metallo-β-lactamases (MBLs) carbapenemase.
Chengcheng Wang +9 more
openaire +3 more sources
Carbapenemases: The never-ending story
Enfermedades infecciosas y microbiologia clinica (English ed.), 2019openaire +3 more sources

